Physician profile
Ali Alsaif
NPI 1013544097
$8,728.18
in general payments reported to CMS, 2019-2025
10 companies · $6,689 in 2025
The $6,689 reported for 2025 was more than what 93% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $104 · 2023: $125 · 2024: $1,811 · 2025: $6,689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,754 · Food and Beverage: $3,860 · Education: $10.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,753.76 |
| Food and Beverage | $3,860.08 |
| Education | $10.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,415.88 | 2024-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Abbott Laboratories | $2,317.45 | 2024-2025 | Proclaim, Eterna |
| Globus Medical, INC. | $917.75 | 2025 | Senza |
| Boston Scientific Corporation | $623.70 | 2024-2025 | Intracept, General - Pain Management |
| Stryker Corporation | $608.97 | 2025 | Mild Device Kit, Spinejack, Optablate |
| Saluda Medical Americas, INC. | $437.91 | 2025 | Evoke |
| Mml US, INC. | $154.46 | 2025 | Reactiv8 |
| Nevro Corp. | $124.71 | 2023 | Senza |
| Relievant Medsystems, INC. | $103.58 | 2022 | |
| Foundation Fusion Solutions, LLC | $23.77 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Alsaif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.